chronic wound
Conditions
Interventions
control group:dressing change by iodophor oil yarn
experimental group:dressing change by recombinant human collagen gel for dressing change
Sponsors
903rd Hospital of PLA
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients treated in the clinical trial center of the project from June 1, 2020 to June 1, 2021; 2. Diagnosed as chronic wound with unlimited etiology, such as bedsore, diabetic foot, etc; 3. No limit to gender and age of patients; 4. It is confirmed by the clinician that the wound needs dressing change; 5. Agree to participate in the study and sign the written informed consent.
Exclusion criteria
Exclusion criteria: 1. Accompanied with life-threatening diseases, such as high-risk coronary heart disease; 2. The nutritional status was very poor, albumin 38.5 degrees C or leukocyte > 12 x 10^9 / L or wound edge redness > 5cm; 4. Patients with deep vein thrombosis of lower extremity and high risk of thrombus risk assessment; 5. Patients who can not cooperate well, such as those with mental illness, or those with poor compliance; 6. Patients who cannot be followed up for a long time; 7. Patients who had a history of allergy or an allergic constitution (allergic to 2 or more allergens) to the ingredients or other chemical structures contained in this product and the control; 8. Pregnant or lactating women and those with fertility plans; 9. Those who have participated in other clinical researches within one month before selection; 10. Other patients who could not be included in the group.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Wound healing rate;Epithelization rate;Wound infection rate;Treatment efficiency;Systemic inflammation;Scar score; | — |
Countries
China
Contacts
Public ContactJin Jian
903rd Hospital of PLA
Outcome results
None listed